EULAR applied for AIFA accreditation and is officially compliant.

Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l

Main contact person: Ms.Cristina Ghidoli
Via G. Ripamonti, 129 - 20141 Milan (Italy)
T +39 02 56601.360, M +39 3428472838
Fax +39 02 70048585

The EULAR 2024 Congress has been awarded with 22.5 CME Credits by EACCME.

Certificate of Attendance (COA) including CME credits of EULAR 2024 will only be available for download and given to delegates who attended the on-site congress 2024 in Vienna. Registered participants who did not attend the onsite congress in Vienna will not have access to the certificate of attendance.

Certificate of Attendance

When you have finalised your congress experience after Saturday, 15 June 2024, please log into your  EULARCongress account. 

A box “Certificate of Attendance” will appear in your account dashboard so you can fill in the survey to obtain your CME certificate.

Once this is done, you can click on "create certificate", which also includes the number of awarded CME points. If you do not fill in the survey, the download button will not appear.


The EULAR 2024 Congress has received the status COMPLIANT.

To see the details, please proceed to this page: EthicalMedtech.